Conference Coverage
Conference Coverage
Myasthenia Gravis: Where Does Traditional Therapy Fit In?
Neurologists debate the data on familiar immunosuppressive agents.
Conference Coverage
New Drug Options Abound for Duchenne Muscular Dystrophy
Mutations are a crucial factor, neurologist says, and steroids still play a role.
Conference Coverage
A Finger-Prick Test for Alzheimer’s Disease?
The DROP-AD project is investigating the diagnostic performance of finger-prick collection to accurately measure p-tau217.
Conference Coverage
New Data on DOAC Initiation After Stroke in AF: Final Word?
Early DOAC initiation was safe with a low rate of symptomatic hemorrhage, regardless of stroke severity.
Conference Coverage
Neurologists Lack Awareness of Steroid Toxicity
Over 85% of survey respondents indicated that a tool for systematically monitoring corticosteroid toxicity would be valuable.
Conference Coverage
Veterans Affairs Hailed as a ‘Bright Spot’ in ALS Care
Transdisciplinary collaboration is essential for maintaining an effective system.
Conference Coverage
Digital Tool May Help Neurologists Assess Steroid Toxicity
The study results “indicate that patients with MG who initiated steroids demonstrated evidence of steroid toxicity in as little as 90 days after...
Conference Coverage
Remote Assessments: A Win-Win for ALS Patients and Clinics?
Remote monitoring of patients with ALS is a feasible option for both maximizing quality of life and minimizing cost and disruption.
Feature
Cannabis in Cancer: What Oncologists and Patients Should Know
Access to and use of cannabis alongside cancer care have outpaced the science on evidence-based indications, according to an ASCO expert panel.
Conference Coverage
Pediatric Myasthenia Gravis: Don’t Treat Children Like Adults
Conference Coverage
New Clinician Tool Aims to Stop ALS Diagnosis Delays
The one-page “thinkALS” tool offers a guide to recognize ALS symptoms and determine when it’s time to refer patients to ALS clinics.